A new modeling study published in JAMA Network Open suggests that offering $100 rideshare rides to patients with abnormal fecal…
Browsing: Clinical Updates
A JAMA Oncology study of over 86,000 patients found that GLP-1 users had reduced overall cancer risk, with particularly lower…
From symptom trackers to multidisciplinary app-based platforms, evidence-based digital therapeutics are expanding access to brain-gut behavioral care for patients with…
Colorectal cancer remains one of the deadliest cancers worldwide, partly because colonoscopies—though highly accurate—are costly and invasive, leading many to…
Guardant Health announced updated clinical results for its Shield™ blood test, showing 84% sensitivity and 90% specificity for detecting colorectal…
Patients are increasingly sharing stool photos with gastroenterologists to better describe symptoms that words may obscure. While sometimes awkward, these…
A prospective study led by Penn Medicine researchers shows that genetic screening for DPYD and UGT1A1 variants before chemotherapy can…
Noncolorectal gastrointestinal cancers — including gastric, esophageal, pancreatic, hepatocellular, biliary tract, and neuroendocrine tumors — are often diagnosed late and…
The FDA has awarded breakthrough device designation to Quest Diagnostics’ Haystack MRD test, a highly sensitive ctDNA assay designed for…
Crohn’s disease is notoriously complex: symptoms often lag behind disease progression, making early diagnosis and intervention difficult. To address this,…